Free Trial

Nutex Health (NASDAQ:NUTX) Releases Quarterly Earnings Results, Beats Expectations By $11.21 EPS

Nutex Health logo with Medical background
Remove Ads

Nutex Health (NASDAQ:NUTX - Get Free Report) released its quarterly earnings results on Monday. The company reported $11.12 earnings per share for the quarter, topping the consensus estimate of ($0.09) by $11.21, Zacks reports. Nutex Health had a negative net margin of 14.09% and a negative return on equity of 51.27%. The business had revenue of $81.30 million for the quarter, compared to the consensus estimate of $81.13 million.

Nutex Health Stock Performance

Nutex Health stock traded down $0.30 during midday trading on Friday, hitting $71.37. The stock had a trading volume of 64,071 shares, compared to its average volume of 52,301. Nutex Health has a 52-week low of $4.16 and a 52-week high of $76.89. The company has a market capitalization of $394.53 million, a PE ratio of -7.60 and a beta of 0.27. The firm's fifty day moving average is $55.05 and its two-hundred day moving average is $38.27. The company has a current ratio of 1.77, a quick ratio of 1.74 and a debt-to-equity ratio of 3.36.

Analyst Ratings Changes

Separately, Maxim Group raised their target price on Nutex Health from $50.00 to $75.00 and gave the stock a "buy" rating in a report on Thursday, February 13th.

Get Our Latest Stock Analysis on NUTX

Hedge Funds Weigh In On Nutex Health

An institutional investor recently raised its position in Nutex Health stock. Bank of America Corp DE increased its position in Nutex Health Inc. (NASDAQ:NUTX - Free Report) by 6,590.3% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 2,074 shares of the company's stock after buying an additional 2,043 shares during the period. Bank of America Corp DE's holdings in Nutex Health were worth $66,000 at the end of the most recent quarter. 5.32% of the stock is currently owned by hedge funds and other institutional investors.

Remove Ads

About Nutex Health

(Get Free Report)

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.

Further Reading

Earnings History for Nutex Health (NASDAQ:NUTX)

Should You Invest $1,000 in Nutex Health Right Now?

Before you consider Nutex Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutex Health wasn't on the list.

While Nutex Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

5 Stocks to BUY Now as Tariff Uncertainty Fades

5 Stocks to BUY Now as Tariff Uncertainty Fades

These 5 Stocks have been beaten down by tariffs, but now that the uncertainty is fading, they're set for a rebound with all the potential downside already priced in.

Related Videos

5 Stocks to BUY Now as Tariff Uncertainty Fades

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads